Determination of lidocaine concentrations producing therapeutic and toxic effects in dogs
Authors:
- 1 June 1983
- journal article
- research article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 6 (2) , 105-111
Abstract
Lidocaine was infused at a fixed zero‐order rate to eight healthy mongrel dogs until tonic extension (n= 5) and cortical seizures (n= 7) were produced. Lidocaine concentrations determined at 5‐min intervals were used to calculate concentrations at which these effects occurred. The tonic extension phase occurred at a mean lidocaine concentration of 8.21 ± 1.69 μg/ml. After a 1‐month rest period, the same dogs were anaesthetized and ventricular tachycardia was produced by administering ouabain. Lidocaine was again infused at a fixed zero‐order rate until all beats of ventricular origin were abolished. This occurred at a mean lidocaine concentration of 6.25 ± 1.49 μg/ml.Keywords
This publication has 5 references indexed in Scilit:
- Pharmacokinetics of lidocaine and its active metabolites in dogsJournal of Veterinary Pharmacology and Therapeutics, 1983
- A rapid analytical procedure for the determination of concentrations of lidocaine and its two active metabolites in canine serumJournal of Veterinary Pharmacology and Therapeutics, 1982
- The Clinical Pharmacology of Lidocaine as an Antiarrhythymic DrugCirculation, 1974
- Antiarrhythmic effects in dogs of lidocaine administered orally and intravenouslyAmerican Heart Journal, 1972
- Intramuscular lidocaine in the therapy of ventricular arrhythmiasThe American Journal of Cardiology, 1971